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Cambridge Vascular Unit, Cambridge University Hospitals, Cambridge, UKThe article by Martin-Gonzalez et al.1 reports a large series of
fenestrated and branched endografts with excellent clinical out-
comes and a 30-daymortality of only 6.2% in this complex patient
group.Thehigh incidence of acute kidney injury (AKI) in this series
of 29% is perhaps the most signiﬁcant ﬁnding. AKI in vascular
surgical patients is associatedwith signiﬁcantly higher 30-day and
1-year mortality rates.2,3 This study further corroborates the as-
sociation between AKI and renal replacement therapy with
postoperative mortality. There is increasing evidence that renal
injury after standard infrarenal EVAR is common and under-re-
ported.4 Furthermore, AKI following EVAR ruptured aneurysm is
also associated with short and longer-term mortality.5
One of the problems with the reporting of renal injury after
AAA repair is the lack of consensus on how it is best recorded.
The authors in addition to renal volume have reported estimated
glomerular ﬁltration rate (eGFR) and used the RIFLE (Risk, Injury,
Failure, Loss, and End-stage) classiﬁcation to deﬁne the inci-
dence of acute renal failure. The Aneurysm Renal Injury Score
(ARISe) a modiﬁcation of RIFLE speciﬁcally aimed at classifying
renal dysfunction after EVAR has the potential to standardize
reporting in this patient group.6
The signiﬁcance of the 14.8% reduction in renal volume at 3-
year follow-up is unclear. These patients are elderly with sig-
niﬁcant co-morbidity and a deterioration of renal function over
time would be anticipated. Unfortunately, because of the
retrospective nature of this study there is no matched control
group to compare the FEVAR and BEVAR patients with, and
therefore the reader is unable to draw robust conclusions
about the signiﬁcance of this ﬁnding.
Furthermore, the usefulness of renal volume as measured on
CT is likely to be limited in clinical practice.There has been amove
away from CT surveillance7 because of concerns about both ra-
diation8 and repetitive contrast-induced renal injury.9 The
question arises: How much of the reduction in renal volume and
eGFR reported in this study were related to CT induced CIN
during follow-up? Data from the contemporary meta-analysis
also suggests a signiﬁcant reduction in creatinine clearance af-
ter standard EVAR at 1 year.4 Teasing out the separate inﬂuences
of the primary intervention, subsequent reinterventions, follow-
up protocols, and factors unrelated to EVAR on longer-term renal
dysfunction require further investigation.DOI of original article: http://dx.doi.org/10.1016/j.ejvs.2015.04.011
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http://dx.doi.org/10.1016/j.ejvs.2015.05.003This recognition of both procedure-related acute renal injury
and the deterioration in renal function over time are important,
becausewithout identiﬁcation of the patient at riskopportunities
to mitigate the renal injury will be missed. Patients undergoing
BEVAR and FEVAR are at high risk of AKI in the perioperative
period, and protocols that include withdrawal of nephrotoxic
drugs, saline pre-hydration, minimizing renal artery instrumen-
tation, and strategies to limit contrast dose should be employed.
It is unlikely that renal volume will have a useful role in moni-
toring renal function over time, which is recognized by the au-
thors; however, eGFR trends in this population warrant further
study.Therapeutic strategies aimed atmitigating AKI alsowarrant
further investigation, as these are likely to reduce both short- and
long-term mortality. Standardized reporting of acute renal injury
after endovascular aneurysm surgery is vital in order to compare
populations and investigate new therapeutic avenues.6REFERENCES
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